TREATMENT OF INITIAL BREAST CANCER (STAGES T1-2A) USING INTRAOPERATIVE RADIOTHERAPY
Keywords:
breast cancer, intraoperative radiotherapy, results, complications, relapseAbstract
Breast cancer (BC) remains an urgent problem worldwide, due to high morbidity and mortality rates. The effectiveness of breast cancer treatment depends on the stage of the tumor process. In the initial forms of breast cancer, organ-preserving methods of treatment are increasingly used. in recent years, the method of intraoperative radiotherapy (IORT) for breast cancer, which is used in the plan of combined treatment, has been actively introduced in the developed countries of the world. Direct imaging of the tumor bed during surgery ensures accurate dose delivery, which has become even more important during the primary reconstruction methods after lumpectomy, since IORT is performed before breast tissue, including parts of the tumor bed, is mobilized for plastic purposes. The article presents the results of treatment of 78 patients with early forms of breast cancer using intraoperative radiation therapy. The treatment was carried out in the Almaty Cancer Center from 2015 to 2018. Intraoperative radiotherapy was performed on the ELLIOT-LIAC device. The safety, efficiency and accuracy of the irradiation method are shown. recurrence of the tumor did not occur in any case.
References
Пак Д. Д., Усов Ф. Н., Фетисова Е. Ю., и др. Современные подходы к лечению больных с карциномой in situ молочной железы //Онкология. — 2013. — № 4. — С. 34—39.
Нургазиев К.Ш., Талаева Ш.Ж., Чичуа Н.А., и др. Новые подходы к терапии больных местно-распространенными и диссеминированными формами рака молочной железы. //Сборник материалов V съезда онкологов Казахстана «Общие вопросы диагностики и лечения опухолей в онкологии», №116, апрель 2014, Алматы.
Kaiser J., Reitsamer R., Kopp P., Gaisberger C., Kopp M., Fischer T., Zehentmayr F., Sedlmayer F., Fastner G. Intraoperative Electron Radiotherapy (IOERT) in the Treatment of Primary Breast Cancer. Breast Care (Basel). 2018. vol. 13. no. 3. P.162-167. doi: https://www.doi.org/10.1159/000489637.
König L., Lang K., Heil J., Golatta M., Major G., Krug D., Hörner-Rieber J., Häfner M.F., Koerber S.A., Harrabi S., Bostel T., Debus J., Uhl M. Acute Toxicity and Early Oncological Outcomes After Intraoperative Electron Radiotherapy (IOERT) as Boost Followed by Whole Breast Irradiation in 157 Early Stage Breast Cancer Patients-First Clinical Results From a Single Center. Front Oncol. 2019. vol. 21. no. 9. P.384. doi: https://www.doi.org/10.3389/fonc.2019.00384.
Reitsamer R., Sedlmayer F., Kopp M., Kametriser G., Menzel C., Deutschmann H. The Salzburg concept of intraoperative radiotherapy for breast cancer: results and considerations. Int J Cancer. 2006. vol. 118. P.2882–7. 10.
Щепотин И.Б., Зотов О.С., Любота Р.В., Аникусько М.Ф., Любота И.И. Молекулярные типы рака грудной железы, определенные на основе иммуногистохимических маркеров: клинико-биологические особенности и прогноз течения. Клиническая онкология. 2012. no№8 (4). С.12-24.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
CC BY-ND
A work licensed in this way allows the following:
1. The freedom to use and perform the work: The licensee must be allowed to make any use, private or public, of the work.
2. The freedom to study the work and apply the information: The licensee must be allowed to examine the work and to use the knowledge gained from the work in any way. The license may not, for example, restrict "reverse engineering."
2. The freedom to redistribute copies: Copies may be sold, swapped or given away for free, in the same form as the original.
